Xconomy: AbbVie News, Articles and Opinions

“abbvie” Archives

Entry	Author	Date	Location
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More	Frank Vinluan	07/19/19	National
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More	Alex Lash	06/28/19	National
AbbVie to Pay $63B for Allergan to Prepare for Life Without Humira	Ben Fidler	06/25/19	Detroit Ann Arbor
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More	Frank Vinluan	06/21/19	National
Oncternal Therapeutics Goes Public After Reverse Merger With GTx	Sarah de Crescenzo	06/12/19	San Diego
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More	Alex Lash	05/24/19	National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More	Frank Vinluan	04/26/19	National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More	Frank Vinluan	03/15/19	National
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away	Alex Lash	02/26/19	National
Voyager Therapeutics, AbbVie Add Parkinson’s to Gene Therapy Pact	Frank Vinluan	02/22/19	Boston
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More	Frank Vinluan	02/22/19	National
AbbVie Joins Myeloma Race with $90M Deal for Rights to Teneobio Drug	Frank Vinluan	02/11/19	San Francisco
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials	Frank Vinluan	02/06/19	San Francisco
Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M	Sarah de Crescenzo	02/06/19	San Diego
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs	Frank Vinluan	01/07/19	San Francisco
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More	Alex Lash	01/04/19	National
Tizona Lands $105M from AbbVie in Cancer Drug R&D Alliance	Frank Vinluan	01/03/19	San Francisco
Acorda Gets FDA Nod for New Parkinson’s Drug, But Rival Looms	Ben Fidler	12/24/18	New York
Gilead, Scholar Rock Sign $80M Up Front Deal for Fibrosis Drugs	Corie Lok	12/19/18	Boston
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2)	Ben Fidler	12/18/18	National
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO	Ben Fidler	12/07/18	National
WI Watchlist: Amazon, JCI, Understory, Titan Spine, Eurofins	Jeff Bauter Engel	11/28/18	Wisconsin
Vertex Hits Again in CF as First Three-Drug Combo Succeeds in Phase 3	Frank Vinluan	11/27/18	Boston
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More	Alex Lash	11/26/18	National
Tocagen Appoints Lori Kunkel as Acting Chief Medical Officer	Sarah de Crescenzo	11/16/18	San Diego
Rainwater Foundation Deploys Millions Toward Rare Brain Disease, PSP	David Holley	11/07/18	Texas
MEI Pharma Inks Cancer Drug Deal with Japan’s Kyowa Hakko Kirin	Sarah de Crescenzo	11/05/18	San Diego
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More	Frank Vinluan	10/26/18	National
Vertex Hums Along as AbbVie Snatches Up a Rival’s CF Drugs for $45M	Ben Fidler	10/25/18	Boston
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End	Ben Fidler	10/19/18	National
Page 1 of 6	next page »